Grantham, Mayo, Van Otterloo & Co (GMO)’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
DKCM
AAMU
Grantham, Mayo, Van Otterloo & Co (GMO)'s QGEN Position: Q3 2020 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Qiagen (QGEN) in Q3 2020, closing a stake of 1,114,409 shares — an estimated $50.6M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in QGEN in Q1 2020 and held it in 2 quarters. The position peaked at $50.6M in Q2 2020. 252 funds tracked by Wall St. Rank hold QGEN as of Q3 2020.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Qiagen position as of Q3 2020 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,114,409 Qiagen shares in Q3 2020, an estimated $50.6M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Qiagen in Q1 2020 and held it in 2 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Qiagen position peaked at $50.6M in Q2 2020.
- 252 funds tracked by Wall St. Rank held Qiagen as of Q3 2020.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2020, filed 13 Nov 2020.